about
Chemical signature of magnetotactic bacteriaPerspectives of breast cancer thermotherapies.Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects.Mass-dependent and -independent signature of Fe isotopes in magnetotactic bacteria.Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: a review.Applications of magnetosomes synthesized by magnetotactic bacteria in medicine.Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field.Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia.Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia.Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field.Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.The V108M mutation decreases the structural stability of catechol O-methyltransferase.Magnetic-field induced rotation of magnetosome chains in silicified magnetotactic bacteria.Glioblastoma Treatments: An Account of Recent Industrial DevelopmentsThe effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating propertiesAssemblies of aligned magnetotactic bacteria and extracted magnetosomes: what is the main factor responsible for the magnetic anisotropy?A Method for Producing Highly Pure Magnetosomes in Large Quantity for Medical Applications Using Magnetospirillum gryphiswaldense MSR-1 Magnetotactic Bacteria Amplified in Minimal Growth MediaIron oxide nanoparticles for therapeutic applicationsBiodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumorsBiodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia diseaseNano-Therapies for Glioblastoma Treatment
P50
Q28649833-93BBEBC5-594D-4E30-BBD6-AE78C6ED2079Q33789409-77978026-235B-49AD-AE86-6C59E0A69B29Q35786517-7BA6C35D-00A0-465B-B1A9-B8FA55EC0839Q36010398-1401A899-C5F5-4473-9162-3EC40428EE7BQ38136251-6BDF6EA8-C6AE-4DE7-AE4F-34CFC237C13BQ38242829-E7B035FD-9782-4B8A-9466-44D98A3C8D77Q38369223-C3621EF7-478F-45A2-975A-EC2798A0E177Q38369423-FB08CF2F-D675-4FEA-8524-9CF4D316D6DCQ39331312-DCF38392-39AB-4333-90CA-CE0E7947325DQ39511966-4AA02657-264C-4F63-BF9D-8F4033F1898FQ42682389-DAF8DB3B-572C-45D2-A6DE-F8034506392CQ44167533-1AD7822B-27B4-4D62-BAD3-02D14E0FA81BQ46599695-223DDFFC-FFCB-4040-BC9D-36FAB5A530E2Q55276705-2B6CE98E-2AC5-4444-BDE3-25F3D91ECA3FQ57111067-72BD1FD3-0B63-4B00-997E-011046E1F886Q63947264-070E7C3E-DD7E-4A84-A785-1D7DEBA8645BQ83877462-74625876-33B0-45D9-A196-8A7EF413D882Q90056914-8DB72A55-191F-4217-AB9A-A8C2270EF1BCQ90505093-48D7A0C7-70F5-4227-9669-893C4FCA1C6DQ92212688-E22F2563-E420-4731-883A-F73655512DFFQ92779432-63A48406-273A-4674-89E5-60C652548788Q92815056-EA8ECE11-7EEE-4E21-95D2-D4466E8CC78E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
E Alphandéry
@en
E Alphandéry
@nl
type
label
E Alphandéry
@en
E Alphandéry
@nl
prefLabel
E Alphandéry
@en
E Alphandéry
@nl
P31
P496
0000-0002-2952-2270